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Abstract
Aim: To explore the functional profile of circulating monocytes and decidual macrophages at term 
human pregnancy and their contribution to tissue repair upon stimulation ex vivo with decidual 
factors and the vasoactive intestinal peptide (VIP).
Methods: Peripheral blood monocytes were isolated from pregnant and non-pregnant volunteers 
and tested in vitro with decidual explants from term placenta and VIP. The effect of VIP on 
decidual explants and the effect of its conditioned media on monocytes or decidual macrophages 
isolated by magnetic beads was carried out by RT-qPCR and ELISA for cytokines expression and 
release. Migration assays were performed in transwell systems.  Efferocytosis was assessed in 
monocytes or decidual macrophages with CFSE-labelled autologous apoptotic neutrophils and 
quantified by flow cytometry. Monocyte and decidual macrophages wound healing capacity was 
evaluated using human endometrial stromal cell monolayers. Immunohistochemistry was 
performed in serial tissue sections of different placentas.
Results: VIP is expressed in the villi as well as in trophoblast giant cells distributed within the 
decidua of term placenta. VIP induced the expression of antiinflmammatory markers and 
monocyte chemoattractant CCL2 and CCL3 in decidual tissues. Monocytes presented higher 
migration towards decidual explants than CD4 and CD8 cells. VIP-conditioned monocytes 
displayed an enhanced efferocytosis and wound healing capacity comparable to that of decidual 
macrophages. Moreover, limited efferocytosis of pregnant women monocytes was restored by 
VIP-induced decidual factors. 
Conclusion: Results show the conditioning of monocytes by decidual factors and VIP to sustain 
processes required for tissue repair and homeostasis maintenance in term placenta.   
Keywords: Macrophages, Repair profile, Pregnancy
Introduction
Decidual macrophages display varying roles throughout pregnancy. They actively participate in 
vascular transformation at early stages and they restore tissue homeostasis after the acute 
inflammatory response that characterizes embryo implantation 1–3. Monocytes are highly recruited 
towards the maternal-fetal interface from the beginning of pregnancy where they differentiate to 
decidual macrophages (dMA) under the control of extravillous trophoblast cells 2. Among several 
factors including chemokines, hormones and growth factors synthesized by decidual cells that 
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has been characterized  4,5. VIP expression in syncyciotrophoblast of first and third trimester 
placentas was formerly reported6 and it was shown to induce progesterone release in placental 
explants and BeWo trophoblast cell line. VIP has been assigned a regulatory role in early human 
pregnancy through targeting trophoblast, decidual cells and macrophages 4,5, neutrophils 7,8 and 
Treg cells 9. VIP modulated trophoblast cell function exhibiting a promigratory and pro-invasive 
effect that depended on specific glucose uptake and mTOR activation in human cytotrophoblast 
cell lines in vitro 10,11. Trophoblastic VIP enhanced apoptotic cell clearance by monocytes with 
increased production of IL-10 5,7. Moreover, VIP silencing in trophoblast cells prevented the 
conditioning of monocytes which showed reduced phagocytosis of apoptotic cells and IL-10 
protein expression 10. In human first trimester placenta, recent evidence indicates that VIP is 
expressed and released by invasive extravillous trophoblast cells 12. VIP localizes in the vascular 
lumen trophoblast cells in 5-9 weeks human placenta and it favors trophoblast outgrowth. At early 
stages, VIP shaped the functional profile of NK cells and dMA isolated from first trimester 
placental explants. Particularly dMA were prompted to a predominant M2 anti-inflammatory profile 
by VIP treatment with an increased IL-10 production without modifying IL-12 levels 12. 
Interestingly, VIP also induced MMP2 expression in dMA from first trimester placenta suggesting 
a possible contribution to sustaining trophoblast invasion and tissue remodeling at early stages 12. 
Although macrophages are found at a constant 20% of immune cells at the decidua until term, 
little is known about monocyte recruitment and profiling at term human placenta. In fact, 
increased pro-inflammatory marker expression is observed in the placenta during the last weeks 
of pregnancy thus preparing the uterus for delivery 13–17. This response is paralleled by tissue 
repairing and anti-inflammatory signals that maintain tissue homeostasis and sustain uterus 
remodelling after delivery 18,19. Decidual macrophages have a central role in these processes 
through apoptotic cell clearance and wound healing followed by the release of anti-inflammatory 
cytokines 20–22. CD36 is a scavenger receptor required for apoptotic cell clearance by 
macrophages in cooperation with thrombospondin, phosphatidylserine receptor and the 
vitronectin receptor (alpha v beta 3)23,24.
Here we propose that decidual factors and VIP modulate the immune microenvironment in term 
human placenta. To test this hypothesis, we used human decidual explants and peripheral blood 
samples in different in vitro and ex vivo models. Results indicate that VIP is expressed in 
extravillous trophoblast giant cells fairly distributed in the decidua of term placenta as well as in 
villous trophoblast cells. VIP induced the expression of anti-inflammatory markers and monocyte 
chemoattractant CCL2 and CCL3 in decidual tissues. Peripheral blood monocytes presented 
higher migration towards decidual explants than CD4 and CD8 cells along with an enhanced 
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Comparative functional profiles of term pregnant vs. non-pregnant monocytes and decidual 
macrophages isolated from term placenta are also shown.
Results
VIP localization in human term placenta
Figure 1A shows that VIP is localized to syncytiotrophoblast and cytotrophoblast cells as well as 
the decidual stroma and fetal vascular tissue within villi (left panel). The right panel 
microphotographs show VIP expression in the decidua in more detail. The strongest 
immunostaining for VIP was revealed in cytokeratin-7 (CK-7+) / vimentin (VIM-) cells fairly 
distributed in the decidual stroma, morphologically consistent with trophoblast giant cells. This 
result suggest that the trophoblast cells are the main source of locally produced VIP in the 
placenta. Other stromal cells scarcely localized in the decidua also show a faint labelling.
VIP modulation of immune markers in decidual explants
Next, we investigated the effect of VIP on decidual markers associated with monocyte profiling. 
We isolated decidua from term placenta explants and incubated the tissue for 20 h with 100 nM 
VIP, a concentration formerly shown to activate trophoblast cell function in first trimester placental 
explants 12. As shown in Figure 1B, decidua of normal gestations at term expresses a relatively 
higher level of monocyte chemoattractant cytokines CCL2 and CXCL8 than pro-inflammatory 
cytokines IL-1β and IL-6. The effect of VIP on these markers is shown in Figure 1C. VIP 
significantly increased CCL2 along with two anti-inflammatory factors IL-10 and IDO whereas it 
reduced IL-1β. CXCL8, TGF-β and IL-6 did not vary with VIP treatment. It is noteworthy that 
CCL3, another monocyte recruitment chemokine, was not detected in the decidua in basal 
conditions, but its expression was induced after VIP treatment (not shown).
Preferential migration of monocytes by decidual factors and VIP
Based on the induction of monocyte chemokine expression in term decidua by VIP, we next 
analysed the specific migration of peripheral blood mononuclear cells (PBMCs) from non-
pregnant volunteers, particularly monocytes (CD14+), CD4+ and CD8+ lymphocytes towards 
decidual conditioned media. Compared to positive control medium (DMEM:F12 10% FCS), 
conditioned media of term decidual explants increased the migration of lymphocytes and 
monocytes. A 3.7-fold increased migration of monocytes towards decidual media vs. basal 
migration was observed compared to less than 1-fold increase for CD4 and CD8 cells migrated 
vs. their basal conditions respectively (Figure 2A). Interestingly, monocytes were by far the most 
recruited population by decidual media, with over 4 times the total amount of CD14+ vs. CD4 and 
over 10 times CD14+ vs. CD8 cells. Of note, peripheral blood mononuclear samples seeded on 
the upper side of the Transwell had a 1:9 CD14:T lymphocyte ratio pointing to the specific 
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was further induced in decidua pre-treated with VIP (Figure 2B). In contrast, VIP-treated decidual 
explants significantly inhibited CD8 lymphocyte migration and showed no effect on CD4 cells 
(Figure 2B).  
Efferocytosis in pregnant vs. non-pregnant monocytes
Decidual macrophages have a central role in the maintenance of tissue homeostasis and for 
sustaining uterus remodelling after delivery through apoptotic cell clearance and wound healing, 
followed by the release of anti-inflammatory cytokines 20–22. Considering that monocytes were 
highly recruited to term decidua and the synergistic effect of VIP, we next explored whether VIP 
and decidual factors induce apoptotic cell phagocytosis in peripheral blood monocytes from either 
non-pregnant or pregnant women. First, a significantly lower efferocytosis rate of monocytes from 
pregnant (P) women compared to non-pregnant (NON-P) donors was observed (Figure 3A). 
When monocytes were exposed to VIP alone no-changes in efferocytosis were found either in 
pregnant or non-pregnant donors. However, an enhanced efferocytosis was evident in monocytes 
that had been conditioned with decidual explants (D) in the presence of VIP. This effect was more 
pronounced in the pregnant donors (Figure 3B and 3C). Since CD36 is a membrane recognition 
molecule involved in apoptotic cell clearance, its potential role in pregnant and non-pregnant 
monocytes’ efferocytosis was next investigated. In line with the results obtained in efferocytosis, a 
higher frequency of CD36 positive cells was induced by decidual factors in non-pregnant 
monocytes whereas in the pregnant women monocytes with lower apoptotic clearance capacity 
this effect was not evident (Figure 3D). 
Wound healing of stromal cells by pregnant vs. non-pregnant monocytes
Monocytes from pregnant and non-pregnant donors were tested for their wound healing capacity. 
Stromal endometrial human cell line (HESC) monolayers were used to assess the wound healing 
effect of monocytes conditioned with VIP, decidual explants’ factors or decidual factors from 
explants pre-treated with VIP in an experimental design similar to assays described above. As 
shown in Figure 4B, monocytes from pregnant women have a higher wound healing capacity 
compared to non-pregnant. The limited wound healing observed with non-pregnant monocytes 
could be boosted by all the three stimuli: VIP, decidual explants (D) and decidual explants pre-
treated with VIP (Figure 4C). The wound healing capacity of P monocytes remained elevated 
without significant changes except with D (VIP) stimulation that increased even further the wound 
healing capacity (Figure 4D). It should be noted that VIP by itself does not increase wound 
healing of endometrial stromal cells and in fact, it is reduced. (Supplementary Figure 1).
VIP on decidual macrophages profile and function
Monocytes recruited to the term placenta differentiate to decidual macrophages. We have 
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inflammatory and pro-invasive markers 12, both signals required at the onset of placentation. 
Tissue repair and homeostasis control are required at delivery, so we next characterized the 
functional profile of dMA isolated from term placenta with special focus on cytokines released, 
efferocytosis and wound healing and the effect of VIP. As shown in Figure 5A, dMA produced and 
secreted TGF-β and low levels of TNF-α and IL-1β. VIP (100 nM) increased TGF-β release but 
did not affect the production of TNF-α nor IL-1β (Figure 5A). Then, we decided to pair monocytes 
from peripheral blood and dMA of the same patient for efferocytosis and wound healing assays. 
Thus, in autologous sampling, dMA presented a higher rate of apoptotic cell phagocytosis 
compared with monocytes from the same pregnant women (Figure 5B). VIP did further increase 
efferocytosis in dMA. As shown above in Figure 4C, the limited extent of efferocytosis capacity of 
monocytes from pregnant women could be restored by decidual explants conditioned with VIP 
reaching efferocytosis rates like dMA (Figure 5B). Wound healing assays revealed that dMA 
display a high tissue repair capacity, comparable to the high capacity shown for monocytes from 
the same pregnant woman. VIP was ineffective in boosting this response on dMA but when P-Mo 
were pre-treated with D (VIP) conditioned media, there was an increment in the wound healing 
capacity. 
Discussion
Functional plasticity characterizes monocyte-derived macrophages in the pregnant uterus from 
implantation to term. In normal pregnancies, they actively participate in trophoblast invasion and 
vascular transformation at early stages, whereas they sustain wound repair and restore tissue 
homeostasis during placentation and until term 25. Due to their critical role in normal and 
complicated pregnancies and their potential as therapeutic targets, the mechanisms involved in 
monocytes recruitment from the periphery to the decidua and their local differentiation and 
conditioning is the matter of continuous study. Here we demonstrated that VIP in a decidual 
context, as well as by itself, contributes to the selective migration and profiling of peripheral 
monocytes from term-pregnant and non-pregnant donors. Monocytes acquire a functional 
phenotype comparable to dMA at this stage. VIP and decidual factors promote apoptotic cell 
clearance, tissue repairing, and anti-inflammatory mediator synthesis in term placenta, consistent 
with the endometrium remodeling events required after placental delivery. Evidence is 
summarized as follows: First, VIP induces monocyte chemoattractant CCL2 and CCL3 in term 
decidual explants and preferentially promotes the migration of peripheral monocytes to decidual 
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peripheral samples tested. Second, critical repairing mechanisms of monocytes and 
macrophages such as efferocytosis, wound healing and anti-inflammatory cytokines synthesis are 
enhanced by VIP-induced decidual factors. Also, limited efferocytosis displayed by peripheral 
monocytes from pregnant women was restored upon stimulation with decidual explants 
pretreated with VIP to levels similar to those in decidual macrophages.  
VIP was formerly described in syncytiotrophoblast, cytotrophoblast cells and vessels of the first 
trimester and term human placenta 6,26. It was also detected in the endometrium, where it plays a 
role in the decidualization process and in the regulation of the immune microenvironment during 
the peri-implantation period 27–30. VIP was recently described in 5-9 weeks decidual explants with 
a strong immunolocalization in invasive extravillous trophoblasts and trophoblast cells in the 
lumen of transforming vessels suggesting a prominent role in vascular remodelling 12. An anti-
inflammatory milieu with increased IL-10 was induced by VIP in decidual macrophages isolated 
from first trimester decidua. Metalloproteinase 2 was also induced by VIP in dMA which could 
assist the trophoblast invasiveness characteristic of this early stage 12. VIP levels in plasma are 
higher in pregnant vs. non-pregnant women and they increase in cord blood and plasma by the 
end of pregnancy 31. Taken together, these observations support the paracrine and systemic 
effects of VIP occurring concomitantly to fit the requirements of the different stages until delivery. 
Our results are in line with a synergistic effect of systemic and decidual VIP. Serum VIP 
concentration range reported for pregnant women (50-150 pg/ml) is comparable to other species 
such as the pregnant rat and mouse 32,33. However, since VIP has a short half-life in serum its 
effects on different tissues are mostly dependent on VIP released by neuronal endings or locally 
synthesized in those tissues: in the pregnant uterus the glandular epithelial cells, trophoblast, 
stromal and vascular cells, all express and release VIP under basal and stimulated conditions 
12,27. A concentration range 1-100 nM was effective to increase trophoblast outgrowth in human 
first trimester placental explants as well as IL-10 release by dMA isolated from same placental 
explants 12. Thus, increasing levels of VIP in plasma and sustained expression of VIP in decidual 
cells would underlie the constant recruitment and profiling of monocytes to differentiate and 
attend the varying demands of the uterus to maintain decidual homeostasis. One of those key 
demands is the constant clearance of apoptotic bodies and cell debris. Differential programming 
of monocytes by systemic and decidual factors to exert a phagocytic function at term is supported 
by the higher efferocytosis of monocytes from non-pregnant compared to pregnant donors shown 
here. The increase of the membrane CD36 phagocytic receptor expression in non-pregnant 
monocytes vs. the lack of CD36 induction in pregnant monocytes is consistent with the poor 
phagocytic capacity of these cells. The relevance of phagocytosis at the maternal-fetal interface 
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phagocytic macrophages to cope with this demand but also the trophoblast cells display 
phagocytosis and efferocytosis as it was previously shown in murine and human cell designs 34–
36. 
Consistent with our present observations, circulating leukocytes from pregnant women presented 
reduced migration index and reduced H2O2 production compared with non-pregnant controls 37. 
Regarding monocyte efferocytosis capacity during pregnancy, pregnant women monocytes are 
less efficient than monocytes from non-pregnant controls and the reduced efferocytic capacity 
was even more pronounced in patients with preeclampsia 38 or systemic lupus erythematosus 39. 
Apoptotic cell clearance is deeply associated with tissue repair mechanisms which are central to 
homeostasis maintenance as well 20,22,40. VIP conditioning of monocytes favored these events in 
the decidua. In fact, monocytes from pregnant women presented higher wound healing capacity 
than monocytes from non-pregnant donors and it was even higher if they were preconditioned 
with decidual factors and VIP. Tissue repair mechanisms are upregulated after delivery in other 
species 18,19,41. Our results support the profiling of circulating monocytes to assist that process 
before delivery thus contributing to mitigate the decidual disruption by repairing uterine structures. 
Monocytes potentiated the wound healing promoted by VIP on stromal cells since HESC 
monolayers treated with VIP in the absence of monocytes not only failed to close the wound but 
also VIP displayed an inhibitory effect. This negative regulation of VIP in endometrial stromal cell 
migration is consistent with the promoting effect of VIP on HESC decidualization previously 
demonstrated 27,42 although this would be at a minimum in term placenta.
Identifying circulatory molecules and/or particles responsible for initiating or exacerbating 
maternal and fetal sickness is crucial to understanding maternal–fetal communication in 
pregnancy pathologies43. The possibility that VIP emerges as a drug candidate for treating term 
pregnancy complications is supported by preclinical studies in murine pregnancy models 28,44–46. 
A single injection of VIP was enough to restore anti-inflammatory mediators synthesis and 
apoptotic cell phagocytosis in abortion prone murine models 44,45. On the other hand, VIP restored 
reduced fetal weight at later stages of pregnancy in a VIP-deficient mouse model 46 and it 
modulated Treg cell outflow to the implantation sites related to VIP local and systemic levels 28..
In the present work we present evidence to demonstrate that in term placenta, decidual 
macrophages and circulating monocytes are conditioned to sustain key processes required for 
tissue repair and homeostasis maintenance. VIP guides monocytes to display a higher migration 
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Term placenta tissue (N=23 in Buenos Aires and N=14 in Sao Paulo) were collected from women 
undergoing programmed caesarean birth. Women participating in the study were 21 to 42 years 
old and all of them had pre-pregnancy BMI 18.5 to 25. They had negative serology for HIV, HBV, 
Chagas disease and Syphilis and no clinical records of gestational diseases or more than one 
pregnancy loss. Samples from women with serious complications during pregnancy such as 
infections that compromised pregnancy or fetal death were excluded. Approval was obtained from 
Hospital Italiano of Buenos Aires Research Ethics Committee (HIBA 1681) and the Institute of 
Biomedical Sciences from University of Sao Paulo (0943/2010). Written informed consent was 
obtained from all women undergoing elective caesarean birth. Placental with decidual basalis 
tissues were dissected as described previously 47 and processed for cell and tissue culture or 
immunohistochemistry assays. Briefly, small decidual explants of 5 x 5 x 1 mm were excised from 
term placenta’s cotyledons, washed with cold PBS and then cultured in 24-well polystyrene plates 
in 500 µl DMEM:F12 complete, with 10% FCS and 100 µg/ml penicillin/ 100 U/ml streptomycin 
(Life Technologies, Buenos Aires, Argentina) for 20 h without or in the presence of 100 nM VIP as 
reported previously 12. The explants were collected for RNA assays in TRizol and the 
supernatants were centrifuged and conserved at -80°C until use.  For immune cell isolation, the 
decidual explants were washed with PBS and digested with collagenase II (1mg/ml) and DNAse I 
(0.1mg/ml) followed by Ficoll-Hypaque centrifugation. Then cells were either used for flow 
cytometry or CD14 cell isolation with magnetic beads coupled to antibodies in a two-step design: 
non-monocyte immune cells were removed using a negative selection CD14 cell isolation kit 
(Miltenyi). Then, monocytes were separated from the recovered cells using a CD45-positive 
selection isolation kit (Miltenyi). In some experiments, cells used for flow cytometry were purified 
directly using a positive selection CD14 cell isolation kit with magnetic beads coupled antibodies 
(Miltenyi).
Blood samples
Blood samples were processed from non-pregnant healthy volunteers (N=13) and pregnant 
(N=12) women at the moment of cesarean birth. Neither donor was under pharmacological 
treatment for at least 10 days before the day of sampling. Blood was obtained by puncture of the 
forearm vein, and it was drawn directly into heparin containing sterile plastic tubes. Studies were 
approved by the Argentine Society of Clinical Investigation Board and Ethical Committee (SAIC 
03/17) and the Hospital Italiano de Buenos Aires Research Ethics Committee and Research 
Committee (HIBA 1681). Samples were collected after corresponding written informed consent 
was signed by the participants. 









This article is protected by copyright. All rights reserved
Peripheral blood mononuclear cells (PBMC) were isolated from individual subjects by Ficoll-
Hypaque and CD14 positive cells separated by Percoll gradient as the manufacturer’s protocol. 
Cell population purity (>80%) was checked by flow cytometry analysis with CD14 labeling as 
previously described 48. Monocytes were cultured in 24-well polystyrene plates (3x105 cells/well) 
in DMEM:F12 complete in the presence or not of 100 nM VIP, or conditioned media of decidua 
explants not treated (D or Decidua) or pre-incubated for 20 h with 100 nM VIP and identified as D 
(VIP) or Decidua VIP; or with first trimester trophoblast cell line, Swan 71 (CT+) for efferocytosis 
assay. Briefly, Swan 71 cells were cultured for 20 h in 24-well flat-bottom polystyrene plates with 
DMEM:F12 10% FCS as reported 5. Cell viability was not affected by the treatments during the 
incubation times used.
Immunohistochemistry
Paraffin-embedded human term placenta with decidua basalis was stained using colorimetric 
detection as described previously. Serial tissue sections (5 µm) were immunostained with anti-
Vimentin-1/100, anti-Cytokeratin-1/100 and anti-VIP-1/500 Abs. Goat anti-mouse HRP- 
conjugated (Thermo Fisher Scientific Cat# 62-6520, RRID:AB_2533947) and Donkey anti-rabbit 
HRP-conjugated antibodies (Thermo Fisher Scientific Cat# PA1-86177, RRID:AB_933717) Abs 
were obtained from Thermo Fischer (1/200) and immunoreactions performed as previously 
reported 12. Microphotographs were acquired using an FV 300® Olympus and Fluoview Software 
FV-ASW 4.1 Viewer. 
Leukocyte migration 
Migration assays were performed in Transwell 24-plates across 5 µm polycarbonate membranes 
(Costar, Corning Incorporated, NY, USA) as previously described 49. PBMCs (2x105 cells) were 
re-suspended in DMEM containing 10% FCS and placed on the upper chamber. The lower 
chamber contained 300 µl of DMEM 10% FCS (basal condition, ―), or conditioned media of 
decidua explants non-treated (D or Decidua) or  that had been pre-treated with 100 nM VIP [D 
(VIP) or Decidua VIP] as indicated. After incubation for 2 h at 37°C, cells were collected, stained 
with anti-CD4+, -CD8+ and -CD14+ antibodies and counted with a FACS Aria II cytometer 
(Becton Dickinson, San José, CA, USA). The results are expressed as the number of cells 
migrated in 2 h. 
Efferocytosis assays
Phagocytosis of apoptotic neutrophils by autologous CD14+ cells (efferocytosis) from non-
pregnant (NON-P) or pregnant (P) blood samples was carried out as previously reported 5,7. 
Neutrophils were obtained after the Ficoll-Hypaque gradient and subsequent Dextran purification 
7,8. Apoptotic neutrophils were obtained after 20 h incubation in RPMI 1640 (spontaneous 
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in RPMI without FCS. Excess of CFSE was eliminated by serial washes with RPMI 10 % FCS. 
The percentage of neutrophil apoptosis was higher than 50% as determined by annexin-
propidium iodide staining and flow cytometry 5,7. In parallel, monocytes (3×105) were conditioned 
for 20 h with 100 nM VIP or decidua explants’ conditioned media without stimuli (D) or pre-
incubated with 100 nM VIP [D (VIP)] or conditioned media from first trimester trophoblast cell line 
Swan 71 as a positive control (CT+) 5 or DMEM:F12 10% FCS as a positive control (BASAL).
Monocytes were incubated with apoptotic neutrophils in a 1:10 ratio. After 40 min of phagocytosis 
monocytes were collected, immunostained for CD14 and the percentage of CD14/CFSE double-
positive cells was analyzed by flow cytometry as described 5,48. 
Cell migration assays 
Wound healing assays were carried out using the Human Endometrial Stromal Cell Line (HESC). 
Briefly, 2×104 cells were plated in 96-well polystyrene plates with DMEM-F12 10% FCS and 
incubated in humidified chamber with 5% CO2 at 37°C. When cells reached confluence, a wound 
was made with a sterile tip and the monolayer was washed to eliminate unattached cells. First, 
we analyzed the effect of VIP in HESC treated with 100 nM VIP, or 100 nM VIP antagonist 
(Synthetic H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-
Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2, BACHEM, USA) or with both for 8 h. Later, we 
evaluated the wound healing-associated factors released by monocytes from either pregnant or 
non-pregnant donors. For this, monocytes were incubated with DMEM F-12 10% FCS, or 100 nM 
VIP or conditioned media of decidual explants pretreated with 100 nM VIP [D (VIP)] or not (D) as 
described for efferocytosis assays above. Photographs were taken at different times in the 
beginning and after 8h and the images were analyzed using the ImageJ program. Results were 
expressed as the percentage of wound healing analyzing the whole wound area. 
RT-qPCR
Decidual gene expression of cytokines [Interleukin (IL) -1β, -6, -10; Indoleamine 2,3-dioxygenase 
(IDO), Transforming growth factor (TGF-) β1 and the chemokines (CCL2, CCL3 and CXCL8) was 
determined by RT-qPCR  as previously described 4,5. Briefly, total RNA was isolated following 
manufacturer recommendations with Trizol reagent (Life Technologies, Grand Island, NY, USA), 
cDNAs generated from 1 ug of RNA using a MMLV reverse transcriptase, RNAsin RNAse 
inhibitor and oligodT kit (Promega Corporation, Madison, WI, USA). Samples were stored at -20 
ºC for batch analysis. 
RT-qPCR master mix (Biodynamics, Buenos Aires, Argentina) was used according to the 
manufacturer`s recommendation. Real-time PCR was performed on a Bio-Rad iQ5 Real-time 
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method (2-△△ CT method) with reference to the endogenous GAPDH control. The primer 
sequences are described in Table I.
Flow cytometry analysis and ELISA
Monocytes or decidual macrophages were cultured in DMEM: F-12 10% FCS without or with 100 
nM VIP, or condition media from decidual explants incubated in DMEM:F12 complete (D) or 
treated with 100 nM VIP [D (VIP)] for 20 hours. Cells were recovered by TrypLE treatment 
(Invitrogen Life Technologies, Grand Island, NY, USA) and stained with APC or FITC conjugated 
mAbs directed to CD14 and CD36, respectively (BD Pharmingen, San Diego, CA, USA) or CD40 
(Immunotools, AP Biotech, Argentina). 
Twenty thousand events were acquired in a FACS Aria II cytometer (Becton Dickinson, San 
José, CA, USA) and results were analyzed using FlowJo software (http://www.flowjo.com/). 
Results were expressed as the percentage of the respective population and the quadrant was set 
using irrelevant isotype-specific Ab. It was expressed as MFI or double positive cell frequencies 
by flow cytometry. Particularly for monocyte profile, positive cells were determined inside the 
electronically gated CD14 positive cell population previously selected in FSC vs. SSC. ELISA was 
performed to assess cytokine levels in dMA supernatants in the presence or not of 100 nM VIP in 
duplicates as previously described (Paparini et al., 2015).
Statistical analysis
The significance of the results was analyzed by Wilcoxon matched-pairs or Mann-Whitney U-test 
for two nonparametric samples. When multiple comparisons were necessary, we used One- or 
two-way ANOVA test followed by Holm-Sidak or Tukey’s multiple comparisson tests. Normality 
was checked with Shapiro-Wilk test before testing. Differences between groups were considered 
significant at P<0.05 using the GraphPad Prism7 software (GraphPad, San Diego, CA, USA). 
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Figure 1: VIP expression and immunomodulatory effect in term human placenta: (A) Serial 
placenta sections were stained with anti-cytokeratin (CK) 7 and anti-vimentin (VIM) (1/200), or 
anti-VIP (1/500) Abs and hematoxylin. Microphotographs were taken with an Olympus 
Microscope in 10X and 40X magnification (squared in the left panel in villi and decidua). Arrows 
are highlighting the same giant trophoblast cells through different staining sections. A 
representative of six different placentas at term gestation is shown. (B) The gene relative 
expression of IL-1β, IL-6, IDO, TGF-β, IL-10, CXCL2 and CXCL8 normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was analysed by RT–qPCR as indicated in Materials and 
Methods. Values represent arbitrary units (A.U.) as mean±S.E.M. of eight term placentas in basal 
conditions. (C) Placental explants were isolated and cultured in DMEM 10% FCS for 20 h in the 
absence (-) or presence of VIP (100 nM). Double gradient heat map with the effect of VIP on 
placenta explants: green (down‐regulated), red (up‐regulated), and black (unchanged). Results 
are expressed as mean ± S.E.M. of fold change. Confidence intervals for VIP treated explants vs. 
non-treated (-) were compared. *P<0.05 of eight different placentas.
Fig 2: Leukocyte selective migration towards the decidua. 2×105 PBMC from healthy non-
pregnant volunteers in DMEM 10% FCS were placed on top of transwell systems and 300 μl of 
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chamber; or (B) 300 µl of conditioned media of decidua explants cultured without (-) or with 100 
nM VIP. Cells in the lower chamber were collected after two hours of migration at 37°C and 
analysed by flow cytometry. Results are mean ± S.E.M. of at least six experiments. *P: 0.05, 
†P<0.01, ‡P: 0.001. Two-way ANOVA. Sidak’s multiple comparison test when there were more 
than 3 conditions and Wilcoxon test when there were 2 conditions.
Fig 3: Efferocytosis of peripheral blood monocytes from pregnant and non-pregnant 
donors. (A) CD14 positive monocytes (3 × 105) from non-pregnant (NON-P) or pregnant (P) 
donors were plated 20 h in DMEM: F12 10% FCS and then challenged with CFSE-labelled 
apoptotic neutrophils (aNeu) (10:1) for 40 min. CD14/CFSE double positive cells were determined 
by flow cytometry. Results are mean±S.E.M. of at least seven independent experiments. *P< 0.05 
Mann-Whitney test. Representative dot plot is shown. (B) NONP or (C) P CD14 positive cells 
were incubated in DMEM:F12 10% FCS (BASAL), with 100 nM VIP (VIP), or decidua conditioned 
media in DMEM:F12 10% FCS (D), or conditioned media from decidua pretreated with 100 nM 
VIP [D (VIP)] or conditioned media from trophoblast cell line as a positive control (CT+) for 20 h. 
Each point represents an independent experiment. Values are median±interquartile range of the 
number of experiments indicated. *P< 0.05, †P< 0.01 and ‡P<0.001, Friedman test, Dunn’s 
multiple comparisons test. (D) The expression of CD36 on CD14 positive cells was determined as 
% of double positive cells from NON-P or P by flow cytometry. Results are represented as 
mean±S.E.M. of at least seven independent experiments. *P<0.05 and †P<0.01. One-way 
ANOVA, Sidak’s multiple comparisons test.
Fig 4: Effect of pregnant and non-pregnant monocytes from peripheral blood on wound 
healing. (A) The diagram shows the experimental design used. (B) A wound was done in a 
HESC monolayer and incubated for 8 h with monocyte conditioned media from NON-P or P 
PBMCs donors. Microphotographs were taken at 0 and 8 h. The wound area was quantified with 
the ImageJ software. Results are expressed as mean±S.E.M. % of wound healing. †P<0.01, 
Mann-Whitney U-test of seven independent experiments. HESC were incubated for 8 h with 
conditioned media from (C) NON-P or (D) P monocytes pre-treated as indicated with 100 nM VIP 
(VIP), decidual explants (D), decidua pretreated with VIP (D VIP) for 20 h or untreated (Basal). 
Results are expressed as mean±S.E.M. % of wound healing. *P<0.05, †P<0.01. One-way 
ANOVA, Sidak’s multiple comparisons test of seven experiments.
Fig 5: Functional characterization of dMA compared to autologous Mo. (A) 3x105 dMA were 
incubated in RPMI 10% FCS in the absence (―) or presence of 100 nM VIP during 20 h and 
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mean±S.E.M. pg/ml. *P<0.05, Mann-Whitney U-test (n=5). (B) and (C) 3x105 dMA were incubated 
in RPMI 10% FCS with 100 nM VIP or not (-). In parallel, 3x 105 peripheral blood Mo from the 
same donor were incubated with RPMI 10% FCS or D (VIP) conditioned media. Then, dMA or Mo 
were used for efferocytosis of apoptotic neutrophils (B) or wound healing assays (C). Values are 
expressed as mean±S.E.M. of double positive CD14/CFSE cells. *P < 0.05; RM-One-way 
ANOVA, Sidak’s multiple comparisons test. Representative dot plots are shown. The wound area 
was quantified with the ImageJ software. Values are mean±S.E.M. % wound healing. *P<0.05; 
RM-One-way ANOVA, Tukey’s multiple comparisons test. Representative microphotographs are 
shown at 0 and 8 h.
Supplementary figure 1: VIP decreased wound healing in HESC. Human endometrial stromal 
cells (HESC) were grown in DMEM:F12 10% FCS until they reached confluence and then 
wounded and incubated in DMEM 10% FCS (―) or 100 nM VIP (VIP), 100 nM of VIP antagonist 
(aVIP) or both (VIP-aVIP) for 8 h. Microphotograph were taken at 0 and 8 h. The wound area was 
quantified with the ImageJ software. (A) Values given are expressed as mean±S.E.M. of the 
percentage of wound healing. *P<0.05; RM-One-way ANOVA, Sidak’s multiple comparisons test 
from 4. (B) A representative experiment is shown.
Physiological relevance:
The recruitment of monocytes and differentiation at the decidua are critical events that determine 
the outcome of pregnancy. Their functional plasticity limits the extent of injury and promotes the 
return to tissue homeostasis from implantation to term. VIP is an immunoregulatory peptide 
synthesized by trophoblast and decidual cells that promotes trophoblast invasion, vascular 
remodeling, and functional shaping of decidual macrophages in first trimester placenta. In the 
present work we provide evidence that in term placenta decidual macrophages and circulating 
monocytes are conditioned to sustain key processes required for tissue repair and homeostasis 
maintenance. Our results also show that VIP guides monocytes to display a higher migration 
towards term decidua and enhances their wound healing capacity.  
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